These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 19471238)

  • 1. Molecular basis of adrenocortical carcinomas.
    Soon PS; Sidhu SB
    Minerva Endocrinol; 2009 Jun; 34(2):137-47. PubMed ID: 19471238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS; McDonald KL; Robinson BG; Sidhu SB
    Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.
    Bussey KJ; Demeure MJ
    Future Oncol; 2009 Jun; 5(5):641-55. PubMed ID: 19519204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenocortical carcinoma.
    Soon PS; Sidhu SB
    Cancer Treat Res; 2010; 153():187-210. PubMed ID: 19957226
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenocortical carcinoma.
    Rodgers SE; Evans DB; Lee JE; Perrier ND
    Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current update on cytogenetics, taxonomy, diagnosis, and management of adrenocortical carcinoma: what radiologists should know.
    Ganeshan D; Bhosale P; Kundra V
    AJR Am J Roentgenol; 2012 Dec; 199(6):1283-93. PubMed ID: 23169720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
    Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
    Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma.
    Giordano TJ
    Am J Surg Pathol; 2011 Apr; 35(4):471-3. PubMed ID: 21383612
    [No Abstract]   [Full Text] [Related]  

  • 9. Current and emerging therapies for adrenocortical carcinoma--review.
    Przytulska J; Rogala N; Bednarek-Tupikowska G
    Adv Clin Exp Med; 2015; 24(2):185-93. PubMed ID: 25931348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in adrenocortical carcinoma in adults.
    Bourdeau I; MacKenzie-Feder J; Lacroix A
    Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):192-7. PubMed ID: 23549307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in adrenocortical tumors.
    Reincke M
    Horm Metab Res; 1998; 30(6-7):447-55. PubMed ID: 9694578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenocortical cancer treatment.
    Patalano A; Brancato V; Mantero F
    Horm Res; 2009 Jan; 71 Suppl 1():99-104. PubMed ID: 19153517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in the treatment of adrenocortical carcinomas].
    Ducry J; Berthold D; Pralong F
    Rev Med Suisse; 2012 Nov; 8(362):2181-4, 2186. PubMed ID: 23240320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenocortical cancer: pathophysiology and clinical management.
    Libè R; Fratticci A; Bertherat J
    Endocr Relat Cancer; 2007 Mar; 14(1):13-28. PubMed ID: 17395972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors.
    Soon PS; Libe R; Benn DE; Gill A; Shaw J; Sywak MS; Groussin L; Bertagna X; Gicquel C; Bertherat J; McDonald KL; Sidhu SB; Robinson BG
    Ann Surg; 2008 Jan; 247(1):157-64. PubMed ID: 18156936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the management of unusual neuroendocrine tumors: pheochromocytoma and paraganglioma, medullary thyroid cancer and adrenocortical carcinoma.
    Strosberg JR
    Semin Oncol; 2013 Feb; 40(1):120-33. PubMed ID: 23391119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a pathway-centered approach for the treatment of adrenocortical carcinoma.
    Bussey KJ; Demeure MJ
    Curr Opin Oncol; 2011 Jan; 23(1):34-44. PubMed ID: 21045685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PERSONALIZED CARE OF PATIENTS WITH ADRENOCORTICAL CARCINOMA: A COMPREHENSIVE APPROACH.
    Miller BS; Else T;
    Endocr Pract; 2017 Jun; 23(6):705-715. PubMed ID: 28614035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocortical carcinoma.
    Baudin E;
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):411-34. PubMed ID: 26038209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.
    Elfiky AA; Krishnan Nair HK
    Discov Med; 2016 Jan; 21(113):49-56. PubMed ID: 26896602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.